Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy

Journal of Neurology

Volumn 260, Issue 4, 2013, Pages 969-974

  Fischmann, Arne ^a   Hafner, Patricia ^a,b   Gloor, Monika ^a   Schmid, Maurice ^b   Klein, Andrea ^c   Pohlman, Urs ^b   Waltz, Tanja ^b   Gonzalez, Rocio ^b   Haas, Tanja ^a   Bieri, Oliver ^a   Fischer, Dirk ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Ambulation; Duchenne muscular dystrophy; Neuromuscular diseases; Quantitative magnetic resonance imaging

Indexed keywords

FAT;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE COURSE; DUCHENNE MUSCULAR DYSTROPHY; EXTENSOR MUSCLE; FLEXOR MUSCLE; HUMAN; KNEE; MOBILIZATION; MOTOR PERFORMANCE; MUSCULOSKELETAL SYSTEM PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; THIGH;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISABILITY EVALUATION; FEMALE; FUNCTIONAL LATERALITY; GAIT DISORDERS, NEUROLOGIC; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; WALKING; YOUNG ADULT;

EID: 84876483438     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6733-x     Document Type: Article

References (24)

1. Manzur AY, Muntoni F (2009) Diagnosis and new treatments in muscular dystrophies. J Neurol Neurosurg Psychiatr 80:706-714. doi: 10.1136/jnnp.2008. 158329
2. Buyse GM, Goemans N, van den Hauwe M, Thijs D, de Groot IJ, Schara U, Ceulemans B, Meier T, Mertens L (2011) Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: results from a 12 month, double-blind, randomized placebo-controlled trial. Neuromuscul Disord 21:396-405. doi: 10.1016/j.nmd.2011.02.016
3. Kinali M, Arechavala-Gomeza V, Feng L, Cirak S, Hunt D, Adkin C, Guglieri M, Ashton E, Abbs S, Nihoyannopoulos P, Garralda ME, Rutherford M, McCulley C, Popplewell L, Graham IR, Dickson G, Wood MJ, Wells DJ, Wilton SD, Kole R, Straub V, Bushby K, Sewry C, Morgan JE, Muntoni F (2009) Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol 8:918-928. doi: 10.1016/S1474-4422(09) 70211-X
4. Vuillerot C, Girardot F, Payan C, Fermanian J, Iwaz J, De Lattre C, Berard C (2010) Monitoring changes and predicting loss of ambulation in Duchenne muscular dystrophy with the motor function measure. Dev Med Child Neurol 52:60-65. doi: 10.1111/j.1469-8749.2009.03316.x
5. Pichiecchio A, Uggetti C, Egitto MG, Berardinelli A, Orcesi S, Gorni KO, Zanardi C, Tagliabue A (2002) Quantitative MR evaluation of body composition in patients with Duchenne muscular dystrophy. Eur Radiol 12:2704-2709. doi: 10.1007/s00330-002-1392-4
6. Garrood P, Hollingsworth K, Eagle M, Aribisala BS, Birchall D, Bushby K, Straub V (2009) MR imaging in Duchenne muscular dystrophy: quantification of T1-weighted signal, contrast uptake, and the effects of exercise. J Magn Reson Imaging 30:1130-1138. doi: 10.1002/jmri.21941
7. Huang Y, Majumdar S, Genant HK, Chan WP, Sharma KR, Yu P, Mynhier M, Miller RG (1994) Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. J Magn Reson Imaging 4:59-64
8. Fischmann A, Gloor M, Fasler S, Haas T, Rodoni Wetzel R, Bieri O, Wetzel S, Heinimann K, Scheffler K, Fischer D (2011) Muscular involvement assessed by MRI correlates to motor function measurement values in oculopharyngeal muscular dystrophy. J Neurol 258:1333-1340. doi: 10.1007/s00415-011-5937-9
9. Sinclair C, Morrow J, Fischmann A, Hanna M, Reilly M, Yousry T, Golay X, Thornton J (2011) Skeletal muscle MRI-determined fat fraction and myometric strength in inclusion body myositis and Charcot-Marie-Tooth disease Type 1A. Neuromuscul Disord 21:S5. doi: 10.1016/S0960-8966(11)70014-1
10. Kinali M, Arechavala-Gomeza V, Cirak S, Glover A, Guglieri M, Feng L, Hollingsworth KG, Hunt D, Jungbluth H, Roper HP, Quinlivan RM, Gosalakkal JA, Jayawant S, Nadeau A, Hughes-Carre L, Manzur AY, Mercuri E, Morgan JE, Straub V, Bushby K, Sewry C, Rutherford M, Muntoni F (2011) Muscle histology vs MRI in Duchenne muscular dystrophy. Neurology 76:346-353. doi: 10.1212/WNL. 0b013e318208811f
11. Liu GC, Jong YJ, Chiang CH, Jaw TS (1993) Duchenne muscular dystrophy: MR grading system with functional correlation. Radiology 186:475-480
12. Bérard C, Payan C, Hodgkinson I, Fermanian J, Group MFMCS (2005) A motor function measure for neuromuscular diseases. Construction and validation study. Neuromuscul Disord 15:463-470
13. Dixon WT (1984) Simple proton spectroscopic imaging. Radiology 153:189-194
14. Sinclair C, Morrow J, Yousry T, Reilly M, Hanna M, Golay X, Thornton J (2010) Inter-scan reproducibility of quantitative neuromuscular MRI. Neuromuscul Disord 20:S28
15. Fischmann A, Hafner P, Fasler S, Gloor M, Bieri O, Studler U, Fischer D (2012) Quantitative MRI can detect subclinical disease progression in muscular dystrophy. J Neurol. doi: 10.1007/s00415-011-6393-2
16. Fischmann A, Kaspar S, Reinhardt J, Gloor M, Stippich C, Fischer D (2012) Exercise might bias Skeletal-Muscle Fat Fraction Calculation from Dixon Images. Neuromuscul Disord 22. doi: 10.1016/j.nmd.2012.05.014
17. Kim HK, Laor T, Horn PS, Wong B (2010) Quantitative assessment of the T2 relaxation time of the gluteus muscles in children with Duchenne muscular dystrophy: a comparative study before and after steroid treatment. Korean J Radiol 11:304-311. doi: 10.3348/kjr.2010.11.3.304
18. Kim HK, Laor T, Horn PS, Racadio JM, Wong B, Dardzinski BJ (2010) T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments. Radiology 255:899-908. doi: 10.1148/radiol.10091547
19. Janiczek RL, Gambarota G, Sinclair CD, Yousry TA, Thornton JS, Golay X, Newbould RD (2011) Simultaneous T(2) and lipid quantitation using IDEAL-CPMG. Magn Reson Med 66:1293-1302. doi: 10.1002/mrm.22916
20. Gaeta M, Messina S, Mileto A, Vita GL, Ascenti G, Vinci S, Bottari A, Vita G, Settineri N, Bruschetta D, Racchiusa S, Minutoli F (2012) Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments: preliminary experience. Skeletal Radiol 41:955-961. doi: 10.1007/s00256-011-1301-5
21. Goutallier D, Postel JM, Bernageau J, Lavau L (1994) Fatty muscle degeneration in cuff ruptures. Pre- and postoperative evaluation by CT scan. Clin Orthop Relat Res 304:78-83
22. Catlin N, Bettelheim K, Henderson I (2011) Individual patient (n = 1) "trials" in Duchenne dystrophy. Neuromuscul Disord 21:525-526. doi: 10.1016/j.nmd.2011.05.003
23. Aartsma-Rus A (2011) The risks of therapeutic misconception and individual patient (n = 1) "trials" in rare diseases such as Duchenne dystrophy. Neuromuscul Disord 21:13-15. doi: 10.1016/j.nmd.2010.09.012
24. Skinner TE, Glover GH (1997) An extended two-point Dixon algorithm for calculating separate water, fat, and B0 images. Magn Reson Med 37:628-630